Tirz is a dual-action peptide developed to target both GIP and GLP-1 receptors. It has become an important subject in metabolic research because of its potential effects on glucose metabolism and weight-related mechanisms. Researchers study it for its ability to influence multiple metabolic pathways simultaneously.

Research indicates Tirz may support appetite control, improve metabolic response, and assist body composition studies. It is also investigated for its potential role in regulating glucose pathways and supporting overall metabolic performance.